Sawaf Aziz has filed 12 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 37500 shares of Theravance Biopharma, Inc. ($TBPH) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 37500 | $0.00 | 353,623.0000 | 51,507,000 | 11.86% | 0.07% |
| Feb. 20, 2026 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 20672 | $19.66 | 316,123.0000 | 51,908,000 | 6.14% | 0.04% |
| Nov. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 18627 | $17.90 | 336,795.0000 | 51,908,000 | 5.24% | 0.04% |
| Aug. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 9368 | $13.39 | 355,422.0000 | 50,726,000 | 2.57% | 0.02% |
| May 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 9348 | $9.45 | 364,790.0000 | 49,706,000 | 2.50% | 0.02% |
| Feb. 28, 2025 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 75000 | $0.00 | 374,138.0000 | 48,847,000 | 25.07% | 0.15% |
| Feb. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 13751 | $9.66 | 299,138.0000 | 48,847,000 | 4.39% | 0.03% |
| Nov. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 8477 | $9.97 | 312,889.0000 | 49,038,000 | 2.64% | 0.02% |
| Aug. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 8635 | $8.22 | 321,366.0000 | 48,747,000 | 2.62% | 0.02% |
| May 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 8635 | $9.10 | 330,001.0000 | 48,283,000 | 2.55% | 0.02% |
| April 2, 2024 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | A | Ordinary Shares | 100000 | $0.00 | 338,636.0000 | 48,283,000 | 41.90% | 0.21% |
| Feb. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | F | Ordinary Shares | 17036 | $8.92 | 238,636.0000 | 55,303,000 | 6.66% | 0.03% |